Novo Nordisk

Drugmaker has seen shares halved as obesity market heats up

Industry has used trade opportunity to hand European Commission a shopping list of asks

Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments

SAP is now Europe’s most valuable public company

Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients

Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now at least

New regulations of pharma sector could cost jobs in Ireland, industry warned Government

Pharma companies ‘disappointed’ in Government’s stance during EU negotiations

Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year

Danish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction

Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately

Iseq index flat as Ryanair adds 1% despite sluggish traffic growth

Indices in Europe end last full trading week with losses as Washington again battles to stop government shutdown

Obesity drug CagriSema misses goal of 25% body weight reduction

Companies competing for leadership in fast-growing market where supply continues to be an issue

Brussels rather than the Trump White House is seen by industry as the more immediate threat to its wellbeing

European Commission has proposed reducing the period of regulatory data protection from eight years to six years

Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination

US packaging giant backing huge demand for injectable obesity drugs to fill the gap left by falling demand for Covid vaccines

Announcement is first major investment by a US multinational following Trump victory in presidential election

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use

Strong day for banking stocks lifts Irish market, while Airbnb and Puma fall after weak outlook statements

Danish company employs about 450 people in Ireland

Seen & Heard: Inheritance tax reduction, Press Up stake and Spar sale

Iseq index outperforms its peers, adding 1.5% after positive updates from Smurfit Kappa and Glenveagh Homes

Europe’s regulations have become ‘too burdensome’ and could hinder innovation, argues Michael Lohan

Continent’s top firms drove most of European equity gains last year

Pan-European Stoxx 600 extends gains and hit a fresh record high, rising 1 per cent

Drug maker trades on multiples unheard of in pharma sector over anticipated sales of weight loss drug

Stocktake: Europe’s most valuable company last week exceeded a market value of $500bn after reporting better-than-expected earnings

The drug maker has struggled to keep up with demand for both Wegovy and Ozempic

From flight cancellation misery and forfeited pay to corporation tax hauls and obesity drug bonanzas, everything in 2023 had either a value or a cost

News of new factory comes after Danish group announced in December the purchase of drug manufacturing plant in Athlone in order to keep up with demand for weight-loss drugs

Pharmaceutical giant suffers a post-Covid-19 hangover as demand for pandemic vaccines and medicines falls sharply

Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments

Proposals would lower time period a company has protection over research behind drugs they develop

Correspondence between health officials details 'high level of concern' about obesity drug shortages

Helge Lund has sought to reassure investors following Looney’s abrupt departure

Company boosted by trial results showing weight loss drug also cuts risk of heart attack by 20%

Planet Business: Pre-Swift concert film hits, Qantas’s under-fire chairman, and the ascent of Novo Nordisk